Sandoz inks deal with Samsung Bioepis to commercialize Stelara biosimilar
Ustekinumab is a fully human monoclonal antibody to interleukin (IL)-12/23, approved for treatment of plaque psoriasis, psoriatic arthritis, Crohn´s disease and ulcerative colitis.